In this episode of Inside the Microcap Markets, Joseph Lucosky breaks down one of the biggest misconceptions currently shaping the microcap and emerging growth markets: the belief that Nasdaq and the New York Stock Exchange still operate the way they did just a few years ago.

For years, Nasdaq was viewed as the more formulaic and accessible exchange for emerging growth companies, while NYSE was seen as more selective and judgment-driven. But as both exchanges continue tightening standards and increasing scrutiny across the listing process, that gap is rapidly narrowing.

Joseph explains why the old “default Nasdaq” mindset no longer works in today’s market and why exchange selection has become a far more strategic decision tied to fit, probability of success, and how a company is likely to be evaluated throughout the process.

In this episode, Joseph covers:

• Why the old perception of Nasdaq vs. NYSE no longer fully applies
• How Nasdaq’s new discretionary environment changed the listing process
• Why the gap between the exchanges is closing on standards, but not process
• How exchange choice now impacts probability of success and deal strategy
• Why pathway analysis and advisor quality matter more than ever in today’s market

As both exchanges continue raising the bar, exchange selection is no longer simply about prestige, familiarity, or historical assumptions. Companies entering the public markets in 2026 are operating in a far more selective environment where structure, positioning, advisor quality, and execution strategy all play a significant role in determining whether a deal ultimately gets through the process.

For more insights from the trenches of the microcap markets, follow Joseph Lucosky on LinkedIn or subscribe to him on Substack. And if you found this episode helpful, please share it with someone in the market. And remember, if you have a question and would like us to answer it on a future episode, please send it to us at questions@lucbro.com

In this episode of Inside the Microcap Markets, Joseph Lucosky examines one of the most controversial proposals currently facing the microcap market: Nasdaq’s proposed $5 million market capitalization delisting rule and the growing pushback it is generating across the public company ecosystem.

What may appear to be a straightforward effort to improve market quality has quickly evolved into a much larger debate about capital formation, investor protection, and whether current market structure policies align with Washington’s stated goal of helping more companies access and remain in the public markets. Drawing from recent meetings on Capitol Hill, Joseph discusses why this issue has become more than just a Nasdaq rule filing and what it could mean for emerging growth companies moving forward.

In this episode, Joseph covers:

• What Nasdaq’s proposed $5 million market cap rule would actually do
• Why critics believe the proposal creates an automatic delisting cliff
• How the rule could impact emerging growth and innovation companies
• The potential effects on capital raising, liquidity, and investor confidence
• Why the proposal is attracting attention from policymakers in Washington

As regulators, exchanges, and lawmakers continue debating the future of the public markets, the outcome of this proposal could have significant implications for smaller public companies and the broader emerging growth ecosystem. For founders, boards, investors, and advisors, understanding the stakes has never been more important.

For more insights from the trenches of the microcap markets, follow Joseph Lucosky on LinkedIn or subscribe to him on Substack. And if you found this episode helpful, please share it with someone in the market. And remember, if you have a question and would like us to answer it on a future episode, please send it to us at questions@lucbro.com

In Episode 2 of Inside the Microcap Markets, Joseph Lucosky breaks down the real story behind Q1 2026 and why the microcap market isn’t disappearing, it’s evolving.

While traditional microcap IPO activity dropped dramatically year over year, the broader market tells a much different story. As exchanges continue tightening standards and increasing discretionary review, founders, bankers, and advisors are increasingly turning toward alternative pathways like uplistings, cross listings, and direct listings.

Joseph explains how the market has moved from a volume-driven environment to a far more selective and strategic one, where structure, positioning, and pathway analysis now matter more than ever.

In this episode, Joseph covers:

• Why Q1 2026 was not simply a “slower” market
• The dramatic decline in traditional microcap IPO volume and what caused it
• How Nasdaq and NYSE rule changes reshaped the landscape
• Why uplistings, cross listings, and direct listings surged in activity
• The growing importance of pathway analysis for founders and advisors
• How foreign private issuers are adapting to the new environment
• Why bigger deals are increasingly favored in today’s market
• What founders, boards, bankers, and consultants should be doing differently right now

Traditional IPO volume may have declined, but activity across alternative pathways accelerated as the market adapted to a more selective and strategic environment. Companies approaching the public markets in 2026 are facing a very different landscape than they were even a year ago, one where structure, positioning, and execution strategy play a far greater role in determining which deals move forward.

For more insights from the trenches of the microcap markets, follow Joseph Lucosky on LinkedIn or subscribe to him on Substack. And if you found this episode helpful, please share it with someone in the market. And remember, if you have a question and would like us to answer it on a future episode, please send it to us at questions@lucbro.com.